Pulse Entdecken nav.journalClub Debatten Trends Forschende Zeitschriften

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Start Entdecken nav.journalClub Trends

⌘+K

Beyond the label: patient-reported outcomes and post-approval communication in oncology | Synapse

April 10, 2026BMJ Oncology0 citationsOpen Access

Beyond the label: patient-reported outcomes and post-approval communication in oncology

JLJens LehmannEuropean Organisation for Research and Treatment of Cancer

Key Points

Explore the importance of patient-reported outcomes in understanding the effectiveness of cancer therapies after approval.
Analysis of patient-reported outcomes data from cancer clinical trials.
Evaluation of post-approval communication strategies regarding new therapies.
Identification of gaps in current communication regarding therapy effectiveness.
Recommendations for enhanced patient engagement in treatment discussions.

Abstract

Cancer clinical trials form the foundation for the approval and use of new anticancer therapies.

KI fragen

Like

Bookmark

Share

View Full Paper

KI fragen

Like

Bookmark

Share

View Full Paper

Cite This Study

Jens Lehmann (Thu,) studied this question.

synapsesocial.com/papers/69d894326c1944d70ce05274 https://doi.org/https://doi.org/10.1136/bmjonc-2026-001082